Cargando…
Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis
BACKGROUND: Being protease inhibitors and owing to their efficacy in SARS-CoV, lopinavir + ritonavir (L/R) combination is being used in the management of COVID-19. In this systematic review and meta-analysis, we have evaluated the comparative safety and efficacy of L/R combination. MATERIALS AND MET...
Autores principales: | Bhattacharyya, Anusuya, Kumar, Subodh, Sarma, Phulen, Kaur, Hardeep, Prajapat, Manisha, Shekhar, Nishant, Bansal, Seema, Avti, Pramod, Hazarika, Mythili, Sharma, Saurabh, Mahendru, Dhruv, Prakash, Ajay, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722914/ https://www.ncbi.nlm.nih.gov/pubmed/33078733 http://dx.doi.org/10.4103/ijp.IJP_627_20 |
Ejemplares similares
-
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021) -
Drug targets for corona virus: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Update on the target structures of SARS-CoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020) -
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
por: Shekhar, Nishant, et al.
Publicado: (2020)